Sam Brusco, Associate Editor01.27.21
Inogen, a medical technology company offering homecare respiratory products, has named Nabil Shabshab as the firm’s president and CEO, effective February 8. Shabshab was also appointed to the Board of Directors, effective February 8. He will succeed Scott Wilkinson, who is retiring as president, CEO, and as a director.
“On behalf of the Board of Directors, I would like to congratulate Nabil on this appointment and thank Scott for his significant contributions to Inogen over the last fifteen years,” Heath Lukatch, Ph.D., Inogen’s Chairman, said in a press release. “During Scott’s tenure with the company, Inogen became the market leader in portable oxygen concentrators, with best-in-class products and an innovative go to market approach. Nabil is a highly talented and experienced executive who we believe will be critical to Inogen’s plans for growth, as we continue to work towards improving the lives of respiratory therapy patients.”
“I am honored for the opportunity to lead Inogen in our mission to increase the freedom and independence for respiratory patients and to make our technologies the standard of care,” said Shabshab. “I look forward to driving the next phase of Inogen’s success as we continue to seek ways to increase patient access to our technologies, expand the impact we have on patients, drive growth business, and increase value for our stockholders.”
“I am grateful to have led this outstanding company and to be a part of improving almost a million patients’ lives with our innovative portable oxygen concentrators,” said the retiring Wilkinson. “As I previously disclosed, this is the right time for me personally to retire as CEO, and I believe that Inogen will continue to increase patient and physician awareness of our products while also focusing on providing excellent service.”
Most recently, Shabshab, 56, served as Worldwide President of Diabetes Care and Digital Health at Becton Dickinson and Company (BD), since August 2017. Prior to that, since August 2011, Shabshab served as BD’s chief marketing officer and executive vice president of strategic planning.
“On behalf of the Board of Directors, I would like to congratulate Nabil on this appointment and thank Scott for his significant contributions to Inogen over the last fifteen years,” Heath Lukatch, Ph.D., Inogen’s Chairman, said in a press release. “During Scott’s tenure with the company, Inogen became the market leader in portable oxygen concentrators, with best-in-class products and an innovative go to market approach. Nabil is a highly talented and experienced executive who we believe will be critical to Inogen’s plans for growth, as we continue to work towards improving the lives of respiratory therapy patients.”
“I am honored for the opportunity to lead Inogen in our mission to increase the freedom and independence for respiratory patients and to make our technologies the standard of care,” said Shabshab. “I look forward to driving the next phase of Inogen’s success as we continue to seek ways to increase patient access to our technologies, expand the impact we have on patients, drive growth business, and increase value for our stockholders.”
“I am grateful to have led this outstanding company and to be a part of improving almost a million patients’ lives with our innovative portable oxygen concentrators,” said the retiring Wilkinson. “As I previously disclosed, this is the right time for me personally to retire as CEO, and I believe that Inogen will continue to increase patient and physician awareness of our products while also focusing on providing excellent service.”
Most recently, Shabshab, 56, served as Worldwide President of Diabetes Care and Digital Health at Becton Dickinson and Company (BD), since August 2017. Prior to that, since August 2011, Shabshab served as BD’s chief marketing officer and executive vice president of strategic planning.
